Showing results (811-820 of 867) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|August 8, 2024
Unraveling the physiological and psychosocial signatures of pain by machine learningNoemi Gozzi, Greta Preatoni, Federico Ciotti, et al.Med (New York, N.Y.)|August 8, 2024
Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative careJonathan Kimmelman, Patrick Bodilly Kane, Selin Bicer, et al.Med (New York, N.Y.)|May 14, 2025
Emerging trends in clinical allogeneic CAR cell therapyYan-Ruide Li, Yichen Zhu, Ying Fang, et al.Med (New York, N.Y.)|May 10, 2025
Bioengineering solutions to improve women's healthCatherine M Klapperich, Gordana Vunjak-Novakovic, Jenny Robinson, et al.Med (New York, N.Y.)|May 10, 2025
Combination of autophagy inhibitors with high-dose CDK4/6 inhibitors offers new hope for advanced HR+/HER2- breast cancerLi-Ping Ge, Yi-Zhou JiangMed (New York, N.Y.)|May 16, 2025
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trialYi Xu, Fen Tian, Hong Ren, et al.Med (New York, N.Y.)|April 12, 2025
AAV gene therapy for mucopolysaccharidosesShaukat Khan, Yasuhiko Ago, Shunji TomatsuMed (New York, N.Y.)|April 12, 2025
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancersKezhong Chen, Anwen Liu, Changli Wang, et al.Med (New York, N.Y.)|April 12, 2025
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trialAnna Brandt, Konrad Klinghammer, Christoph Schultheiss, et al.Med (New York, N.Y.)|April 12, 2025
AMPLIFY: A second-generation BTK inhibitor for fixed-duration therapy in chronic lymphocytic leukemiaStefano MolicaPageof 87